Back to results
US 2019/0314272 A1Published application
Stable Liquid Antibody Formulation
AssigneePfizer Inc.
InventorsAdvait Vijay Badkar, Leigh Kristen Bohack, Kevin Roger King, Atlanta Lea Lary
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by a liquid formulation of a humanised anti-NGF antibody.
Claims34
A liquid composition comprising;
- at least one antibody,
- at least one tonicity agent,
- at least one buffer,
- at least one chelating agent,
- at least one surfactant,
- wherein the pH of said composition is from 5.8 to 6.8.
3 more elements
Dependencies are inferred from the claim text.